Eli Lilly opens new diabetes-focused R&D center in China
10:05 EDT 1 Jun 2012 | Pharmaceutical Business Review
Eli Lilly and Company has officially opened the Lilly China Research and Development Center (LCRDC), a diabetes-focused research and development center in Shanghai, China.
Original Article: Eli Lilly opens new diabetes-focused R&D center in China
More From BioPortfolio on "Eli Lilly opens new diabetes-focused R&D center in China"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
